©2018 by APMI

In an interview with NeurologyLive®, Harald J. Hampel, MD, PhD, MA, MSc, discussed why the company has stayed the course on the amyloid theory despite many signals pointing in other directions

Published: December 30, 2019

Eisai Stays the Course on Amyloid Despite Setbacks

https://www.neurologylive.com/journals/neurologylive/2019/december-2019/eisai-stays-the-course-on-amyloid-despite-setbacks